MarketScreener Editorial Features Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 10/12/2025			5-day change	1st Jan Change
185,700.00 ^KRW	-0.85%		+0.81%	+3.00%

12-03	Celltrion Announces U.S. FDA Approval of 300mg strength of OMLYCLO®?	CI
11-28	Celltrion, Inc. Receives Health Canada Approval for Eydenzelt®?, a Biosimilar Confirming Eylea®? (aflibercept 2Mg)	CI

	The Fed Can't Save Everyone	September 24, 2025 at 01:54 pm
	Confidence on Hold Until Powell Weighs In	September 23, 2025 at 01:58 pm
	Trump makes Wall Street shine and depresses Europe	November 11, 2024 at 01:41 pm
	Central banks to the rescue	March 21, 2023 at 01:59 pm

No results for this search